ARCHITECT INSULIN 08K41-26

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01 report with the FDA on 2014-06-17 for ARCHITECT INSULIN 08K41-26 manufactured by Abbott Laboratories.

Event Text Entries

[19404849] The customer questioned the higher than expected architect insulin results generated from one patient sample. The customer stated that a result of 26 uiu/ml was suspected since the patient has a result of 0. 01 ng/ml for the c-peptide assay. The customer indicated that the patient did not take any medication that could have an effect on the insulin results. The customer then performed a dilution and results of 34. 1 and 24. 4 were then generated for the insulin. No impact to patient management was reported.
Patient Sequence No: 1, Text Type: D, B5


[19454183] (b)(4). Product evaluation is in process and the results will be submitted in a follow-up report.
Patient Sequence No: 1, Text Type: N, H10


[25060175] Product evaluation was performed in order to investigate this issue. Review of ticket trending and a lot search did not identify atypical complaint activity related to this issue. Accuracy testing was completed using retained kits of reagent lot 37020lp55. Acceptance criteria were met, which indicates acceptable product performance. A deficiency was not identified as panel testing shows that the likely cause lot performed per specification. No malfunction is suggested since this issue was limited to a discreet patient sample and assay values obtained through a dilution study performed by the customer generated similar results. There is no performance claim for this assay and additional issues were identified.
Patient Sequence No: 1, Text Type: N, H10


[26508685] Product evaluation is in process and the results will be submitted in a follow-up report.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1415939-2014-00126
MDR Report Key3878373
Report Source01
Date Received2014-06-17
Date of Report2014-05-29
Date Mfgr Received2014-09-29
Device Manufacturer Date2013-12-01
Date Added to Maude2014-07-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT LABORATORIES
Manufacturer Street100 ABBOTT PARK ROAD
Manufacturer CityABBOTT PARK IL 60064350
Manufacturer CountryUS
Manufacturer Postal Code60064 3500
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARCHITECT INSULIN
Generic NameINSULIN
Product CodeCFP
Date Received2014-06-17
Catalog Number08K41-26
Lot Number37020LP55
Device Expiration Date2014-12-03
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT LABORATORIES
Manufacturer Address100 ABBOTT PARK ROAD ABBOTT PARK IL 60064350 US 60064 3500


Patients

Patient NumberTreatmentOutcomeDate
10 2014-06-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.